109 related articles for article (PubMed ID: 84550)
1. [Effect of S-adenosyl-L-methionine on the cerebral and peripheral metabolism of L-dopa].
Bidard JN; Fonlupt P; Cronenberger L; Pacheco H
Arch Int Physiol Biochim; 1978 Oct; 86(4):715-24. PubMed ID: 84550
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of S-adenosyl-L-methionine on catecholaminergic central function.
Losada ME; Rubio MC
Eur J Pharmacol; 1989 Apr; 163(2-3):353-6. PubMed ID: 2566505
[TBL] [Abstract][Full Text] [Related]
3. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
Waldmeier PC; Maître L
Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
[TBL] [Abstract][Full Text] [Related]
4. Decrease of noradrenaline O-methylation in rat brain induced by L-dopa. Reversal effect of S-adenosyl-L-methionine.
Stramentinoli G; Catto E; Algeri S
J Pharm Pharmacol; 1980 Jun; 32(6):430-1. PubMed ID: 6106679
[No Abstract] [Full Text] [Related]
5. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
Nguyen TB; Angers M
Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
[TBL] [Abstract][Full Text] [Related]
6. Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity.
Blessing H; Bareiss M; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2003 Jan; 42(2):139-51. PubMed ID: 12421594
[TBL] [Abstract][Full Text] [Related]
7. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
[TBL] [Abstract][Full Text] [Related]
8. The use of 3H-dopa for studying cerebral catecholamine metabolism.
Persson T; Waldeck B
Acta Pharmacol Toxicol (Copenh); 1968; 26(4):363-72. PubMed ID: 5755483
[No Abstract] [Full Text] [Related]
9. [Effect of halothane on catecholamine metabolism in the brain stem of rats].
Schulte J
Arzneimittelforschung; 1976; 26(3):324-7. PubMed ID: 989321
[TBL] [Abstract][Full Text] [Related]
10. The effect of amitriptyline, desipramine and imipramine on the vivo brain synthesis of 3H-noradrenaline from 3H-L-dopa in the rat.
Nielsen M; Eplov L; Scheel-Krüger J
Psychopharmacologia; 1975; 41(3):249-54. PubMed ID: 1098088
[TBL] [Abstract][Full Text] [Related]
11. Uptake of monoamines into central neurones and the blood-brain barrier in the infant rat.
Loizou LA
Br J Pharmacol; 1970 Dec; 40(4):800-13. PubMed ID: 5495178
[TBL] [Abstract][Full Text] [Related]
12. The cerebral metabolism of L-dihydroxyphenylalanine. An autoradiographic and biochemical study.
Horne MK; Cheng CH; Wooten GF
Pharmacology; 1984; 28(1):12-26. PubMed ID: 6701184
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
Melega WP; Luxen A; Perlmutter MM; Nissenson CH; Phelps ME; Barrio JR
Biochem Pharmacol; 1990 Jun; 39(12):1853-60. PubMed ID: 2112915
[TBL] [Abstract][Full Text] [Related]
14. S-adenosyl-L-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms.
Crowell BG; Benson R; Shockley D; Charlton CG
Behav Neural Biol; 1993 May; 59(3):186-93. PubMed ID: 8503824
[TBL] [Abstract][Full Text] [Related]
15. Consequences of monoamine oxidase inhibition: increased vesicular accumulation of dopamine and norepinephrine and increased metabolism by catechol-O-methyltransferase and phenolsulfotransferase.
Buu NT; Lussier C
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):563-8. PubMed ID: 2748880
[TBL] [Abstract][Full Text] [Related]
16. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons.
Storch A; Blessing H; Bareiss M; Jankowski S; Ling ZD; Carvey P; Schwarz J
Mol Pharmacol; 2000 Mar; 57(3):589-94. PubMed ID: 10692500
[TBL] [Abstract][Full Text] [Related]
17. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
Weiss BF; Roel LE; Munro HN; Wurtman RJ
Adv Neurol; 1974; 5():87-99. PubMed ID: 4155238
[No Abstract] [Full Text] [Related]
18. Conversion of 3, 4-dihydroxyphenylalanine and deuterated 3, 4-dihydroxyphenylalanine to alcoholic metabolites of catecholamines in rat brain.
Edwards DJ; Rizk M
J Neurochem; 1981 May; 36(5):1641-7. PubMed ID: 6165806
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa.
Charlton CG; Crowell B
Pharmacol Biochem Behav; 1992 Oct; 43(2):423-31. PubMed ID: 1359575
[TBL] [Abstract][Full Text] [Related]
20. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
